Evidence map›Paper›PMID 41718956›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2026

Feasibility and acute outcomes of cavotricuspid isthmus ablation using the circular-array pulsed field system.

Rimpei Ueno, Shuhei Arai, Yoshimi Onishi, Masaya Ochiai, Yoshikazu Suzuki, Yosuke Kai, Takamasa Ishikawa, Yuki Takai, Haruka Miyazaki, Hiroto Sugiyama and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rimpei Ueno *Division of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Shuhei Arai *Division of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan. shuheiara7@med.showa-u.ac.jp.ORCID http://orcid.org/0000-0001-8048-4890
Yoshimi OnishiDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Masaya OchiaiDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Yoshikazu SuzukiDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Yosuke KaiDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Takamasa IshikawaDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Yuki TakaiDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Haruka MiyazakiDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Hiroto SugiyamaDivision of Cardiology, Department of Medicine, Showa Medical University Fujigaoka Hospital, Yokohama, Japan.
Yuya NakamuraDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Taku AsanoDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Toshiro ShinkeDivision of Cardiology, Department of Medicine, Showa Medical University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulsed-field ablation (PFA) is a novel nonthermal energy source that has shown favorable procedural safety and efficiency in pulmonary vein isolation. However, its utility in cavotricuspid isthmus (CTI) ablation, particularly with circular-array catheters, remains uncertain.

objectivesTo evaluate the feasibility, acute efficacy, procedural characteristics, and complication profile of CTI ablation using a circular-array PFA system.

methodsThis retrospective study included 55 consecutive patients who underwent CTI ablation with a circular PFA catheter. Procedural parameters—including comparisons with radiofrequency (RF) ablation—PQ intervals, voltage mapping, and adverse events were analyzed.

resultsBidirectional CTI block was achieved in all patients. The median number of applications to achieve block was three, with a total of eight applications per case. The median time to block and total ablation time were significantly shorter than those observed with RF ablation (79 sec vs. 324 sec; p < 0.001, 291 sec vs. 432 sec; p = 0.003). High-density mapping demonstrated extensive low-voltage lesions, with a median minimum width of 18 mm (IQR: 12–23) and maximum width of 30 mm (IQR: 23–35). Coronary spasm occurred in three patients (5.5%) but resolved with vasodilators.

conclusionsCTI ablation performed in conjunction with atrial fibrillation ablation using a circular-array PFA system appears to be a feasible and time-efficient approach. In the absence of prophylactic vasodilator administration, coronary spasm was observed even with the circular-array PFA system, underscoring the need for further investigation under vasodilator-supported conditions. Circular-array PFA created extensive low-voltage lesions with short procedural time and achieved 100% acute CTI block. Procedural efficiency was unaffected by right atrial volume or CTI length, while coronary spasm occasionally occurred in the absence of vasodilators, warranting further evaluation under vasodilator pretreatment.

Indexed as

AblationCavotricuspid isthmus ablationCircular-array pulsed field systemEchocardiographyIntracardiacPulsed field ablationSpasm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.